Literature DB >> 17692242

[Changes in the prevalence of asthma in the Spanish cohort of the European Community Respiratory Health Survey (ECRHS-II)].

Isabel Urrutia1, Urko Aguirre, Jordi Sunyer, Estel Plana, Nerea Muniozguren, Jesús Martínez-Moratalla, Félix Payo, José Antonio Maldonado, Josep Maria Anto.   

Abstract

OBJECTIVE: The rise in the prevalence of asthma in the second half of the 20th century has not been evenly distributed according to recent surveys. We assessed changes in the prevalence of asthma after a period of 9 to 10 years in a cohort of young adults in the Spanish arm of the European Community Respiratory Health Survey (ECRHS).
MATERIAL AND METHODS: The ECRHS-II is a multicenter cohort study taking place in 27 centers around Europe, with Spanish centers located in Albacete, Barcelona, Galdakao, Huelva, and Oviedo. The ECRHS questionnaire was administered to individuals who had participated in the first phase of the survey; spirometry and methacholine challenge tests were also performed according to the published protocol.
RESULTS: Among new smokers, the prevalence of wheezing in the last 12 months increased from 10% to 33%, while the frequency of phlegm production rose from 8% to 22% (P< .05). In ex-smokers, the prevalences of wheezing and phlegm production decreased from 21% to 12% and from 15% to 8%, respectively (P< .05). Symptom prevalences remained similar for never smokers, although the frequency of diagnosed asthma rose from 4% to 7% (P< .05). After adjusting for smoking, age, sex, and center, we found no significant differences in the frequency of symptoms or asthma, even when the phrase bronchial hyperreactivity was included in the definition. However, the rate of reported asthma rose annually by 0.34% (95% confidence interval [CI], 0.20%-0.48%), while diagnosed asthma rose by 0.26% (95% CI, 0.13%-0.39%) and treated asthma by 0.16% (95% CI, 0.07%-0.25%).
CONCLUSIONS: Increased prevalence rates of asthma diagnosis and treatment have been detected, but the rates of reported symptoms have remained similar, consistent with the assumption that more persons are being classified as asthmatics.

Entities:  

Mesh:

Year:  2007        PMID: 17692242     DOI: 10.1016/s1579-2129(07)60098-6

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  12 in total

1.  Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.

Authors:  Marta Rava; Maciej J Czachorowski; Debra Silverman; Mirari Márquez; Sirish Kishore; Adonina Tardón; Consol Serra; Montse García-Closas; Reina Garcia-Closas; Alfredo Carrato; Nathaniel Rothman; Francisco X Real; Manolis Kogevinas; Núria Malats
Journal:  Int J Cancer       Date:  2017-10-16       Impact factor: 7.396

2.  Prevalence of Work-Related Asthma in Primary Health Care: Study Rationale and Design.

Authors:  Ventura Rabell-Santacana; Rafael Panadès-Valls; Rosa Vila-Rigat; Enric Hernandez-Huet; Joan Sivecas-Maristany; Xavier Blanché-Prat; Gemma Prieto; Laura Muñoz; Pere Torán
Journal:  Open Respir Med J       Date:  2015-11-13

3.  Accreditation of specialized asthma units for adults in Spain: an applicable experience for the management of difficult-to-control asthma.

Authors:  Carolina Cisneros; Rocío Magdalena Díaz-Campos; Núria Marina; Carlos Melero; Alicia Padilla; Silvia Pascual; Celia Pinedo; Andrea Trisán
Journal:  J Asthma Allergy       Date:  2017-05-09

4.  Asthma and COPD in Hospitalized COVID-19 Patients.

Authors:  Eduardo García-Pachón; Lucía Zamora-Molina; María J Soler-Sempere; Carlos Baeza-Martínez; Justo Grau-Delgado; Isabel Padilla-Navas; Félix Gutiérrez
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-05-31       Impact factor: 4.872

5.  Effectiveness and Safety of Bronchial Thermoplasty in Severe Asthma in Clinical Practice in Spain.

Authors:  Luis Puente-Maestu; Milagros Llanos Flores; Paola Benedetti; Ingrid Frías Benzant; Alicia Oliva Ramos; Julia García de Pedro; Pilar Sanz Sanz; Javier García-López
Journal:  Biomed Hub       Date:  2018-11-01

6.  The association between asthma control, health care costs, and quality of life in France and Spain.

Authors:  Marianne Doz; Christos Chouaid; Laure Com-Ruelle; Eduardo Calvo; Max Brosa; Julien Robert; Laurent Decuypère; Celine Pribil; Alicia Huerta; Bruno Detournay
Journal:  BMC Pulm Med       Date:  2013-03-22       Impact factor: 3.317

7.  Trends in the use of antiasthmatic medications in Morocco (1999-2010).

Authors:  Imane Ghanname; Samir Ahid; Ghizlane Berrada; Abdelmjid Belaiche; Mohamed Hassar; Yahya Cherrah
Journal:  Springerplus       Date:  2013-03-05

8.  Trends in adult asthma hospitalization: gender-age effect.

Authors:  Francisco J Gonzalez-Barcala; Jorge Aboal; Luis Valdes; José M Carreira; Jose M Alvarez-Dobaño; Amalia Puga; María Teresa Garcia-Sanz; Bahi Takkouche
Journal:  Multidiscip Respir Med       Date:  2011-04-30

9.  A budget impact analysis of Spiromax(®) compared with Turbuhaler(®) for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions.

Authors:  Josep Darbà; Gabriela Ramírez; Juan L García-Rivero; Sagrario Mayoralas-Alises; José Francisco Pascual; Albert Roger; Diego Vargas; Adi Bijedic
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-06

10.  Factors associated with asthma control: MOSAR study (Multicenter Observational Study of Asthma in Rabat-Morocco).

Authors:  Imane Ghanname; Ahmed Chaker; Abha Cherkani Hassani; Laila Herrak; Serge Arnaul Ebongue; Mustapha Laine; Khalid Rahhali; Abdelhak Zoglat; Aida Maria Benitez Rexach; Samir Ahid; Yahia Cherrah
Journal:  BMC Pulm Med       Date:  2018-04-24       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.